Senior Scientist, Innate Immunity & Cancer Cell Death Biology

Role summary

Written by MyIslandJob from the job title and employer. See the employer's page for the full description.

This role requires a PhD or equivalent experience in immunology, cancer biology, cell biology, molecular biology, or a related discipline, with strong expertise in innate immune signaling and regulated cancer cell death. Experience designing and executing complex in-vitro and in-vivo studies, interpreting scientific data, publishing research, and collaborating across drug-discovery teams is expected. The successful candidate should be scientifically creative, capable of independently driving projects, and comfortable presenting findings to internal and external audiences. Astellas will expect strong communication, careful documentation, teamwork, and the ability to translate emerging biology into innovative therapeutic opportunities.

About the employer

Astellas Pharma Inc. is a Japan-based global pharmaceutical company headquartered in Tokyo, with research, development, and commercial operations across North America, Europe, and Asia. The company focuses on innovative medicines in areas including oncology, immunology, neuroscience, urology, and rare diseases. Astellas emphasizes research-driven drug discovery and works through internal science, external partnerships, and collaboration with academic institutions. Its mission is to turn innovative science into value for patients whose medical needs remain unmet. The company employs international teams and supports multidisciplinary work spanning basic research, clinical development, regulatory affairs, manufacturing, and commercialization. This position sits within Astellas's discovery research environment, where laboratory science in innate immunity and cancer cell death may contribute to the identification and development of new oncology treatments.